FDMT
4d Molecular Therapeutics, Inc.
Clinical-stage gene therapy company
CUSIP: 35104E100HealthcareUS1 holder
Total Value
$93.51M
Total Shares
2.93M
Net Share Change
-1.85M
Activity
1 selling
Investor
Value
Shares
Weight
Change
Viking Global Investors
$93.51M2.93M shares
TRIM-1.85M(-38.7%)